Exercise training improves HR responses and V̇O2peak in predialysis kidney patients

Medicine and Science in Sports and Exercise

Volumn 44, Issue 12, 2012, Pages 2392-2399

  Headley, Samuel ^a   Germain, Michael ^b   Milch, Charles ^a   Pescatello, Linda ^c   Coughlin, Mary Ann ^a   Nindl, Bradley C ^d   Cornelius, Allen ^e   Sullivan, Sheila ^f   Gregory, Sara ^a   Wood, Richard ^a  

^a SPRINGFIELD COLLEGE   (United States)

^b Western New England Renal and Transplant Associates   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^e University of the Rockies   (United States)

^f BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Autonomic nervous system; Chronic kidney disease; HR; HR recovery

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEASIBILITY STUDY; HEART RATE; HUMAN; KIDNEY FUNCTION TEST; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; CHOLESTEROL, LDL; EXERCISE; FEASIBILITY STUDIES; HEART RATE; HUMANS; KIDNEY FUNCTION TESTS; MIDDLE AGED; MONITORING, AMBULATORY; OXYGEN CONSUMPTION; PILOT PROJECTS; RENAL INSUFFICIENCY, CHRONIC; TRIGLYCERIDES; YOUNG ADULT;

EID: 84870064370     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318268c70c     Document Type: Article

References (34)

1. Boger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med. 2006; 38:126-36.
2. Boyce ML, Robergs RA, Avasthi PS, et al. Exercise training by individuals with predialysis renal failure: cardiorespiratory endurance, hypertension, and renal function. Am J Kidney Dis. 1997; 30(2):180-92.
3. Brotman DJ, Bash LD, Qayyum R, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol. 2010;21(9):1560-70.
4. Clements L, Ashurst I. Dietary strategies to halt the progression of chronic kidney disease. EDTNA ERCA J. 2006;32(4):192-7.
5. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341(18):1351-7. (Pubitemid 29503574)
6. Dattilo AM, Kris-Etherton P. Effects of weight reduction on blood lipids and lipoproteins: a meta-Analysis. Am J Clin Nutr. 1992;56(2): 320-8.
7. Eidemak I, Haaber AB, Feldt-Rasmussen B, Kanstrup I, Strandgaard S. Exercise training and the progression of chronic renal failure. Nephron. 1997;75:36-40.
8. Fouque D, Aparicio M. Eleven reasons to control the protein intake of patients with chronic kidney disease. Nat Clin Pract Nephrol. 2007;3(7):383-92.
9. Heifets M, Davis TA, Tegtmeyer E, Klahr S. Exercise training ameliorates progressive renal disease in rats with subtotal nephrectomy. Kidney Int. 1987;32:815-20.
10. Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011;10:CD003236.
11. Hoefner DM, Hodel SD, O'Brien JF, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem. 2001;47(2):266-74.
12. Johansen KL, Painter P. Exercise in individuals with CKD. Am J Kidney Dis. 2011;59(1):132-40.
13. Kent PS. Integrating clinical nutrition practice guidelines in chronic kidney disease. Nutr Clin Pract. 2005;20(2):213-7. (Pubitemid 43093068)
14. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-A meta-Analysis. Nephrol Dial Transplant. 2006;21: 2446-51.
15. Lauer MS. Autonomic function and prognosis. Cleve Clin J Med. 2009;76(Suppl 2):S18-22.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999; 16(1306):461-70.
17. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-54.
18. Levey AS, Greene T, Beck GJ, et al. Dietary protein restriction and progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol. 1999;10(10):24-6.
19. Levey AS, Greene T, Sarnak MJ, et al. Effect of dietary protein restriction on the progression of kidney disease: long-Term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 2006;48(6):879-88.
20. Levey AS, Tangri N, Stevens LA. Classification of chronic kidney disease: a step forward. Ann Intern Med. 2011;154(1):65-7.
21. Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res. 2010;33(6):521-8.
22. Osato S, Onoyama K, Okuda S, Sanai T, Fujishima M. Effect of swimming exercise on the progression of renal dysfunction in rat with focal glomerulosclerosis. Nephron. 1990;55:306-11.
23. Penne EL, Neumann J, Klein IH, Oey PL, Bots ML, Blankestijn PJ. Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment. J Nephrol. 2009;22(2):208-15.
24. Ribeiro F, Alves AJ, Duarte JA, Oliveira J. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol. 2010;141(3):214-21.
25. Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20(5):933-9.
26. Schnabel R, Blankenberg S, Lubos E, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease. Circ Res. 2005;97:1-7.
27. Silverstein DM. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2009;24(8):1445-52.
28. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009;20:2305-13.
29. Thompson WR. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia, Pennsylvania: Lippincott Williams 2010. p. 380.
30. Toyama K, Sugiyama S, Oka H, Sumida H, Ogawa H. Exercise therapy correlates with improving renal function through modifying lipid metabolism in patients with cardiovascular disease and chronic kidney disease. J Cardiol. 2010;56(2):142-6.
31. US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. 2008. ch 1: p. 1-6.
32. Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol. 2010; 6(5):287-96.
33. Wilund K, Tomayko E, Wu E, et al. Inflammatory response to exercise training in chronic kidney disease. MSSE. 2009;41(5):S42.
34. Yilmaz MI, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences. Clin Nephrol. 2007;68:1-9. (Pubitemid 47045486)